ST Bailing announced that a total of 12 of its main products have been included in the National Essential Medicines List, 2026 edition, effective from September 1, 2026. The included products comprise the core exclusive product Yindan Xinnaotong Soft Capsules, as well as Xiaoer Chaigui Tuire Granules, Hugan Tablets, and Qiangli Pipa Syrup. The company stated that the inclusion will facilitate the promotion and use of these products in medical institutions at all levels, positively impacting market expansion and long-term development. However, specific sales are subject to multiple factors and remain uncertain, and the impact on current performance cannot be accurately estimated at this time.
Guizhou Bailing Group Pharmaceutical Co Ltd12 products included in National Essential Medicines List, expected to boost hospital adoption and sales.